A postulated role for transcriptional regulator LMO2 in the proliferation and involution of hemangioma
- 1 January 2006
- journal article
- Published by Elsevier in Medical Hypotheses
- Vol. 67 (5) , 1230-1232
- https://doi.org/10.1016/j.mehy.2006.04.045
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Myeloid Cells in Infantile HemangiomaThe American Journal of Pathology, 2006
- Tracing the hemangioblast during embryogenesis: developmental relationships between endothelial and hematopoietic cellsThe International Journal of Developmental Biology, 2005
- Lmo2 and Scl/Tal1 convert non-axial mesoderm into haemangioblasts which differentiate into endothelial cells in the absence of Gata1Development, 2003
- The LIM-domain protein Lmo2 is a key regulator of tumour angiogenesis: a new anti-angiogenesis drug targetOncogene, 2002
- Kissing Cousins—evidence for a common vascular cell precursor.Nature Medicine, 2000
- Vascular anomaliesPublished by Elsevier ,2000
- The oncogenic LIM-only transcription factor Lmo2 regulates angiogenesis but not vasculogenesis in miceProceedings of the National Academy of Sciences, 2000
- The oncogenic T cell LIM-protein Lmo2 forms part of a DNA-binding complex specifically in immature TcellsThe EMBO Journal, 1998
- Cellular markers that distinguish the phases of hemangioma during infancy and childhood.Journal of Clinical Investigation, 1994
- The rhombotin family of cysteine-rich LIM-domain oncogenes: distinct members are involved in T-cell translocations to human chromosomes 11p15 and 11p13.Proceedings of the National Academy of Sciences, 1991